Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels

NCT06334575 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

135

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Budesonide

Sponsor

Maria Joyera Rodríguez